Citigroup Initiates AbbVie With Sell

Analysts at Citigroup initiated coverage on

with a Sell rating. The target price for AbbVie is set to $48. AbbVie shares have gained 14.83% over the past 52 weeks, while the S&P 500 index has surged 14.57% in the same period. AbbVie's shares closed at $56.90 in pre-market trading.